Time New York: Wed 13 Dec 21:26 pm  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

Second Sight Medical (EYES) in Focus: Stock Moves 12.1% Higher

Zacks

Second Sight Medical Products Inc. EYES was a big mover last session, as the company saw its shares rise more than 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company for the company—as the stock is now up 6% in the past one-month time frame.

The company has seen a mixed track record when it comes to estimate revisions of no increase decrease over the past few weeks, while the Zacks Consensus Estimate for the current quarter has remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Second Sight Medical currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Second Sight Medical Products, Inc. Price


A better-ranked stock in the Medical sector is Apollo Endosurgery, Inc. APEN which carries a Zacks Rank #2 (Buy).You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Is EYES going up? Or down? Predict to see what others think: Up or Down.

Zacks' Hidden Trades

While we share many recommendations and ideas with the public, certain moves are hidden from everyone but selected members of our portfolio services. Would you like to peek behind the curtain today and view them?

Starting now, for the next month, I invite you to follow all Zacks' private buys and sells in real time from value to momentum…from stocks under $10 to ETF to option movers…from insider trades to companies that are about to report positive earnings surprises (we've called them with 80%+ accuracy). You can even look inside portfolios so exclusive that they are normally closed to new investors.

Click here for Zacks' secret trade>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.